Scientology: Hollywood's Favorite Religion is Nothing More Than An Empty Shell
- Andy Morgan
- in
- Culture,
- Religion
- 21 hours ago
Buzzfeed recently published an in-depth study of scientology’s self destruction. Even though Scientology donors are richer than ever, the church is about to implode because the membership simply is not there.
The Church of Scientology (CSI) has centralized its money and bureaucracy since founder L. Ron Hubbard’s death in 1986. The original, successful model was built around license products and services for a small fee to local franchises, and only occasionally called for large cash donations to the central organization for special projects. Although it has always been a church based on paid membership, local organizers were relatively free to purchase and maintain church property, market services, and raise funds.
Today, the organization has raised a billion dollar war-chest and built several extravagant campuses. Several high-ranking members have defected since 2005 after being duped into donating huge amounts of money — entire retirement plans or mortgages — that simply went to the central agency.
What’s more, the CSI uses high-profile, expensive building projects to mask extremely inflated numbers and raise more funds. The CSI headquarters in Los Angeles claims that 60 such “cathedrals” are underway for the “millions” of scientologists, making 2013 a “banner year” for the church. But according to an independent survey, there are only 25,000 self-identifying scientologists in the U.S. (the same survey counted 340,000 wiccans).
The outlandish basis of scientology and its cultic, secretive hierarchy mixed with a decade of bad press would be enough to destroy more stable organizations. But scientology has traded the stability of middle-class members for less stable million-dollar donors, who are nearly tapped out. We should expect to see that war-chest exhausted in the next few years propping up a dead shell.
24
Going Clear: Scientology, Hollywood & the Prison of Belief by Lawrence Wright – review
From reincarnation to revenge to extraterrestrial time travel, a straight-faced and scrupulous exploration of Scientology's dark and outlandish belief system
Lafayette Ronald Hubbard published Dianetics: The Modern Science of Mental Health in 1950. According to Bridge Publications, itself an arm of the Church of Scientology, at least 80 million copies have been sold. That sounds possible, if you credit the church's claim that it has 8 million members. But then you have to reckon with more objective external estimates that the membership might be just 50,000, while one assumes that the book sales are inflated by deliberate bulk-buying by church members. So what are you going to believe?
Here's a quick experiment. Amazon ranks books according to their current sales. I thought I would compare Dianetics with Ayn Rand's Atlas Shrugged. The Rand novel was published in 1957 and it apparently has a devoted readership eager to believe in the free mind solving all problems. My experiment was conducted on 20 January 2013. The hardback of Atlas Shrugged was then ranked 62,059, the Kindle edition at 976 and the paperback at 416. I was surprised and impressed, but I've seen people on buses, in parks and at the beach reading Atlas Shrugged. I have never seen anyone reading Dianetics, and this might be why: the hardback is ranked at 402,370 and the paperback at 24,618. There isn't a Kindle edition, but the audio book is ranked at 318,283.
All of which would begin to bear out the thought that there can't be that many people who would fall for the preposterous doctrine of Scientology, or be ready to tolerate the ugly behaviour of its church. Admittedly, that is a personal opinion, but on your behalf I have acquired it from reading Lawrence Wright's account of this phenomenon. His book is admirably judicious and thoroughly researched (within the limits of secrecy or paranoia imposed by the church), but I often had the feeling that Wright himself was uncertain whether this was fit material for a sober book of non-fiction, or would he collapse in fits of helpless laughter and tears at the stuff he was obliged to report? Even if the church had just three remaining members (Tom Cruise, John Travolta and its present leader, David Miscavige), it would be a demented venture worthy of Mel Brooks orMonty Python.
When I say on your behalf, I have to tell you, and remind myself, that fears of litigation are preventing publication of this book in Britain. Both the Church of Scientology and Tom Cruise have a history of being litigiously aggressive, and both have denied the veracity of a great deal of the material in the book.
Hubbard was one of the great scoundrel tricksters of American history (the competition is intense); a man who was fuelled and inspired by his own myth, a flamboyant charismatic, inclined to bombast, fantasy and running for cover whenever the heat came on. He was a drop-out and drifter, returned to shore by the navy in wartime because he was deemed unfit to command, as well as a womaniser and a betrayer, and a liar not just from expediency but because it was his calling. He was also a writer of pulp fiction, and what prepared the way for the language and delirium ofDianetics was several years of writing adventure-packed short stories and science fiction junk novels.
Wright is scrupulous and straight-faced in describing the self-help philosophy that emerged. At its heart was this proposition: if you feel troubled, inadequate and wasted in life, come listen to this. Life was proposed as an eternal force, always threatened by the negativity of "en-grams" – any destructive or dishonest urges you might be subject to. The way to conquer these bugs was through auditing, a prolonged process of being talked to by trained auditors who took you back over the details of your life – into the womb and beyond. A machine, the E-meter, was invaluable in these auditing procedures, detecting tiny skin deviations in nervous reaction.
Yes, it sounds like a lie detector, and the whole method seems like a version of psychotherapy in which problems are talked out until the subject can recognise them and deal with them. Put aside the machine and the jargon and you can see how the prospect might appeal to some people. But there was more to it. According to Wright, the audited confessions were often recorded, filed away and likely to be used as blackmail if the subject felt he or she had had enough. At that stage, the bill for the auditing could be delivered, and it was sometimes in six figures. The goal of the enterprise was for the subject to reach the status of "Clear". At first hardly anyone got there, but then gradually it spread: Clears were thick on the ground, even if some ran amok or killed themselves soon after they made the grade. Nicole Kidman "went Clear in no time".
As Wright tells it, behind the promise of self-help lay extortion, intimidation and a kind of imprisonment that makes one think of Soviet history. If you did a bad thing in Scientology, such as questioning Hubbard or joking at the fatuous pomp of the enterprise, you might be rounded on and generally humiliated. Hubbard himself was an astute paranoid. To every innocent suggestion that getting Clear sounded like clearing your mind through psychotherapy, the "church" said no, because psychiatry is the devil and must be attacked.
Scientology is now famous for revenge and the obsessive pursuit of its own righteousness. The most striking example of that is not the suicides or the disintegration of some miscreants, nor the reported church-ordered divorces; it's the way Miscavige launched a campaign against the Internal Revenue Service to deter it from ending the church's tax-exempt status. Wright has it that scientology deluged the IRS with lawsuits that began to impair its regular functioning – and so in 1993 the government caved in, no matter that the threatened bill for tax arrears would have terminated the church. Hubbard died in 1986, but his voice is still out there, and heard by the lucky ones such as Miscavige (who dropped out of school at the age of 16, and is now said to have a net worth of $50 million).
Much of this is hard to believe, and Wright, previously the author ofThe Looming Tower, a history of the ideology of terrorism, has armed himself with detailed source notes and regular footnotes to the effect that the church or Tom Cruise's lawyers "deny this ever happened". And this is where "Hollywood" gets into the subtitle. It's true that the church was as keen to get Hollywood names on to its books as the House UnAmerican Activities Committee was to name movie people who might be reds. But this is not really a book about show business, and I wonder if "Hollywood" hasn't been pushed up front out of publishing's needs. Moreover, if the church reckoned that Cruise would be a draw for recruits, I suspect the unstable life and antics of the 50-year-old actor have done more to discredit than assist Scientology.
The subject of this book starts off as astounding, to be sure. (Hubbard's early stories were for the Astounding Science-Fiction magazine. In Scientology, he kept many elements of extra-terrestrial time travel and reincarnation: he reckoned that when he died, he would become a heavenly body, twinkling in the Kubrickian depths.) But it is so crammed with unpleasant people and degrading stories, and so helplessly clotted with Scientology jargon and acronyms, that it's not easy reading. Nothing dispels the feeling that Scientology was a horror and farce that was dwindling in advance of this book.
Of course, the church has given Wright very little help (and perhaps some hindrance). In the popular estimate today, I think that Scientology is considered less as a way to better mental health than as a means of thought control, punishment and vindictive pursuit, founded and managed in fear, not hope. Wright points out that there are countries (Germany for one) where Scientology has come close to being outlawed.
So it's a very American dream, and there is a natural affinity with Hollywood in that it preys on an idea of fantastic escape. But if you look again, it's alarming to realise how thoroughly the legend of escape becomes a new kind of prison. Being Clear is an inducement to darkness and disarray. You may laugh at it at first, but get ready to weep.
• David Thomson's The Big Screen is published by Allen Lane.
Read more: http://www.sfgate.com/business/article/Robert-Duggan-Scientology-s-biggest-donor-4234071.php#ixzz2JTzHfWAF
Robert Duggan Scientology's biggest donor
Brendan Coffey
Updated 8:09 pm, Tuesday, January 29, 2013
He's the Church of Scientology's biggest donor, and now, worth more than a billion dollars.
Since taking over biotech firm Pharmacyclics Inc. in a 2008 boardroom coup, Chief Executive Officer Robert W. Duggan has led the Sunnyvale company to new heights, thanks primarily to an experimental treatment for chronic lymphocytic leukemia.
Pharmacyclics' medicine, called ibrutinib, inhibits an enzyme that promotes cancer growth. It helped control the malignancy in 68 percent of 116 patients who hadn't been previously treated for the blood cancer, it reported last month.
"It's not just promising, it has those unique profiles of looking very efficacious but also really safe," said John McCamant, editor of Medical Technology Stock Letter. "That is very rare in cancer drugs."
After seeing his company's shares triple in value last year, Duggan, 68, has a net worth of at least $1.2 billion, according to the Bloomberg Billionaires Index.
"It is our collective desire to usher in a new era of patient-friendly, body-harmonious, medicinal therapy to cancer patients in need. While much work remains, we are off to a very good start," Duggan said Tuesday.
The goal is to use the drug without chemotherapy, a standard treatment that can be too toxic for some elderly patients. Ibrutinib may generate as much as $5 billion a year if approved for CLL and other blood cancers, said Michael Yee, an RBC Capital Markets analyst, in December.
In December 2011, pharmaceutical giant Johnson & Johnson said it would pay Pharmacyclics as much as $975 million to fund getting the drug to market in exchange for half the profits generated globally.
There are 27 human trials of ibrutinib completed, under way or planned. McCamant said he believes the company will begin selling the drug in 2014. He said it also has a good chance of developing additional usages for the drug, such as treating autoimmune disorders.
Duggan, a Berkeley native, owns almost 20 percent of Pharmacyclics shares, and controls another 500,000 shares he manages on behalf of undisclosed high net worth individuals, according to filings with the U.S. Securities and Exchange Commission.
The billionaire bought most of his shares from 2004 through 2011, at a cost of $42 million, including shares he received as repayment of $6 million he loaned the company, according to data compiled by Bloomberg. They are valued at about $975 million.
He also has at least $250 million in cash and other investable assets, based upon an analysis of past investments, stock sales and purchases, taxes and charitable giving, according to the Bloomberg ranking. His past ventures have included a bakery chain, a European billboard operation and a robotic surgery innovator.
"Duggan is the undisputed champion of donations to Scientology Inc.," Rathbun said. "He is in a category of his own, having donated more than $20 million. Nobody else even comes close to having donated that much."
Those donations have funded a cruise ship for the religion's retreats, backed missions in Italy and provided thousands of copies of "Dianetics," a book by Scientology's founder, L. Ron Hubbard, to libraries across the U.S.
"Scientology and what it has made available to me in the way of courses and other programs has steered me in the direction of becoming a better and more capable person. Thus I feel it is an honor and personal obligation to share my financial success with Scientology," Duggan said.
Since taking over biotech firm Pharmacyclics Inc. in a 2008 boardroom coup, Chief Executive Officer Robert W. Duggan has led the Sunnyvale company to new heights, thanks primarily to an experimental treatment for chronic lymphocytic leukemia.
Pharmacyclics' medicine, called ibrutinib, inhibits an enzyme that promotes cancer growth. It helped control the malignancy in 68 percent of 116 patients who hadn't been previously treated for the blood cancer, it reported last month.
"It's not just promising, it has those unique profiles of looking very efficacious but also really safe," said John McCamant, editor of Medical Technology Stock Letter. "That is very rare in cancer drugs."
After seeing his company's shares triple in value last year, Duggan, 68, has a net worth of at least $1.2 billion, according to the Bloomberg Billionaires Index.
"It is our collective desire to usher in a new era of patient-friendly, body-harmonious, medicinal therapy to cancer patients in need. While much work remains, we are off to a very good start," Duggan said Tuesday.
Johnson & Johnson
Ibrutinib, which is delivered by pill and is in Phase III drug trials - the last hurdle before market introduction - is part of a new class of medicines for chronic lymphocytic leukemia, or CLL, a cancer that strikes about 16,000 Americans a year at a median age of about 72.The goal is to use the drug without chemotherapy, a standard treatment that can be too toxic for some elderly patients. Ibrutinib may generate as much as $5 billion a year if approved for CLL and other blood cancers, said Michael Yee, an RBC Capital Markets analyst, in December.
In December 2011, pharmaceutical giant Johnson & Johnson said it would pay Pharmacyclics as much as $975 million to fund getting the drug to market in exchange for half the profits generated globally.
There are 27 human trials of ibrutinib completed, under way or planned. McCamant said he believes the company will begin selling the drug in 2014. He said it also has a good chance of developing additional usages for the drug, such as treating autoimmune disorders.
Largest shareholder
Pharmacyclics generated $103 million in revenue in the quarter that ended Sept. 30, up from $37,000 a year earlier. Of the 13 analysts who cover the company, 62 percent have a buy rating on the stock, with an average target price of $80.38 per share, according to data compiled by Bloomberg. The stock was down 3 percent Tuesday to $67.82.Duggan, a Berkeley native, owns almost 20 percent of Pharmacyclics shares, and controls another 500,000 shares he manages on behalf of undisclosed high net worth individuals, according to filings with the U.S. Securities and Exchange Commission.
The billionaire bought most of his shares from 2004 through 2011, at a cost of $42 million, including shares he received as repayment of $6 million he loaned the company, according to data compiled by Bloomberg. They are valued at about $975 million.
He also has at least $250 million in cash and other investable assets, based upon an analysis of past investments, stock sales and purchases, taxes and charitable giving, according to the Bloomberg ranking. His past ventures have included a bakery chain, a European billboard operation and a robotic surgery innovator.
'Scientology Inc.'
One big recipient of Duggan's giving is the Church of Scientology. The billionaire is the church's largest financial supporter, according to Mark "Marty" Rathbun, former inspector general of Scientology, the second-highest leadership post in the organization. Rathbun left the organization in 2004 because he said the church had strayed from its founder's intent."Duggan is the undisputed champion of donations to Scientology Inc.," Rathbun said. "He is in a category of his own, having donated more than $20 million. Nobody else even comes close to having donated that much."
Those donations have funded a cruise ship for the religion's retreats, backed missions in Italy and provided thousands of copies of "Dianetics," a book by Scientology's founder, L. Ron Hubbard, to libraries across the U.S.
"Scientology and what it has made available to me in the way of courses and other programs has steered me in the direction of becoming a better and more capable person. Thus I feel it is an honor and personal obligation to share my financial success with Scientology," Duggan said.
Brendan Coffey is a Bloomberg writer. E-mail: bcoffey10@bloomberg.net
Read more: http://www.sfgate.com/business/article/Robert-Duggan-Scientology-s-biggest-donor-4234071.php#ixzz2JTzHfWAF
0 comments:
Post a Comment